Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.
Shanmuganathan N, Wadham C, Shahrin N, Feng J, Thomson D, Wang P, Saunders V, Kok CH, King RM, Kenyon RR, Lin M, Pagani IS, Ross DM, Yong ASM, Grigg AP, Mills AK, Schwarer AP, Braley J, Altamura H, Yeung DT, Scott HS, Schreiber AW, Hughes TP, Branford S.
Shanmuganathan N, et al. Among authors: yeung dt.
Haematologica. 2023 Sep 1;108(9):2380-2395. doi: 10.3324/haematol.2022.282184.
Haematologica. 2023.
PMID: 36951160
Free PMC article.